TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments
  • Shareholders Foundation monitors Class Action Investigations, Cases, and Class Action Settlements.
    Learn More >>>
  • Create Notifications and monitor one Case or multiple Cases. Or submit your entire portfolio! Learn More >>>

Indevus Pharmaceuticals (NASDAQ: IDEV) Investors Update: Investigation Over Proposed Acquisition By Endo Pharmaceuticals As Unfair; What Do The Investors Think: Is the Offered Price 'Unfair'?

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

Endo Pharmaceuticals announced to acquire Indevus Pharmaceuticals (NASDAQ: IDEV) for $4.50 cash for each share of Indevus Pharmaceuticals (NASDAQ: IDEV). According to a recent press release an investigation on behalf of Indevus Pharmaceuticals (NASDAQ: IDEV) investors over possible shareholder claims arising from potential breaches of fiduciary duty and other violations of state law b...



You must register (for free) or login to view the entire investigation.

Click here to Sign In or Register (for a free account)